On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and ...

Mission Statement: Bring affordable innovative technology to health and fitness that fulfills unmet need while reducing complications. AIO Breathe oral appliance for Obstructive Sleep Apnea in ...

Pediatric OSAS treatment is shifting towards a tailored, multidisciplinary approach, moving beyond a one-size-fits-all model. Adenotonsillectomy is the standard first-line treatment, improving sleep ...

TAMPA, Fla. — Get a good night's rest and it normally leads to a more productive, better day. However, sleep apnea stops peaceful slumber for millions of adults. Tampa General Hospital's Ear, Nose & ...

LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...

AAP updates pediatric sleep apnea guidelines The American Academy of Pediatrics has released revised clinical practice guidelines for treating children with obstructive sleep apnea. HealthDay News — ...

LITTLETON, Colo., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the ...

Children with obstructive sleep apnea have almost three times the risk for high blood pressure in their teen years than their peers, researchers say. However, scientists funded by the National Heart, ...

Please provide your email address to receive an email when new articles are posted on . Children with obstructive sleep apnea experienced increased risk for future hypertension when the sleep disorder ...

Please provide your email address to receive an email when new articles are posted on . From 2012 to 2021, use of high-flow nasal cannula, noninvasive positive pressure ventilation and CPAP ...